HepB and Asians

HBV disproportionately affects
Asian and Pacific Islanders (APIs).

The 3-shot hepatitis B vaccine can provide lifelong protection against HBV, thus eliminating the most common cause of liver cancer.

Of all the people with chronic HBV infection in the world, approximately two-thirds live in Asia with 93 million in China alone.


As many as 1 in 12 Asians and foreign-born Asian Americans is living with chronic HBV infection, compared to 1 in 1000 in the non-Asian U.S. population.


Although Asian Americans make up only 4% of the U.S. population, they account for over half of the estimated 1.25 million individuals with chronic HBV infection.


Liver cancer caused by chronic HBV infection is the second leading cause of cancer death for Asian men living in the United States.


Liver cancer incidence is up to 8 times higher in Asian American men than in their white counterparts.


Hepatitis B and liver cancer constitute the greatest health disparity between Asian and white Americans.


2 out of 3 API tested positive are not aware they are infected.